Capsovision, INC S-1 registration statements

CapsoVision, Inc. has filed a registration statement for the resale of 2,867,089 shares of common stock issued in a March 2026 private placement.

CapsoVision, Inc., a medical technology company specializing in capsule endoscopy, is launching an initial public offering of 5,250,000 shares at an anticipated price range of $5.00 to $5.50 per share, aiming to raise approximately $22.83 million in net proceeds to fund R&D and general corporate purposes, despite a history of net losses and substantial doubt about its ability to continue as a going concern.

CapsoVision, Inc., a medical technology company specializing in capsule endoscopy, filed an S-1/A registration statement for its initial public offering of 5,250,000 shares at an anticipated price range of $5.00 to $5.50 per share, aiming to raise approximately $22.83 million in net proceeds to fund R&D, repay a loan, and support general corporate purposes, despite a history of significant net losses and an auditor's going concern warning.

CapsoVision, Inc., a medical technology company specializing in capsule endoscopy, is seeking to raise approximately $22.83 million in its initial public offering to fund product development and commercial expansion, despite a history of net losses and auditor-raised substantial doubt about its ability to continue as a going concern.

CapsoVision, a medical technology company specializing in gastrointestinal diagnostics, has filed an S-1 registration statement for an initial public offering to support its growth strategies, including obtaining FDA clearance for its CapsoCam Colon capsule.